No Data
Kawasaki Kisen Kaisha, Asahi Kasei, etc. [List of stock information from the newspaper]
Kawasaki Heavy Industries, Ltd. <7012> will enter the civil aircraft engine MRO in the fiscal year 2026, and will enhance the structure of its two factories in Hyogo (Nikkan Kogyo front page) - ○ Subaru Corp Unsponsored ADR <7270> adopts On Semiconductor's image sensor for "EyeSight" (Nikkan Kogyo page 3) - ○ Sumitomo Metal Mining Co., Ltd. <5713> nickel-based cathode material plant for automotive use to start operation in January next year (Nikkan Kogyo page 3) - ○ Asics Corporation <7936> upwardly revises its three-year mid-term plan, raising its operating income to over 130 billion yen (Nikkan Kogyo page 3) - ○ Canadivya <7004>
List of Cloud Breakout Stocks [Ichimoku Balance Table, List of Cloud Breakout Stocks]
○ List of stocks breaking through the clouds in the market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo main board <1433> Bestera 948 947 871.5 <1820> Nishimatsu Construction 5150 5123468.5 <1860> Toda Corporation 1003959.7 5994.5 <1871> PS 10491034.7 5956 <1884> Nihon Doro 1696 1684.7 51597.5
The rebound also functions with the 200-day line as a support.
The Nikkei average rebounded. It closed the trading at 38,414.43 yen, up 193.58 yen (approximately 1.8 billion shares in volume), following the trend in the US market. It started with a rebound, recovering the milestone of 38,500 yen just after the opening. However, active buying was limited, and there were scenes where the price increase narrowed to 38,246.36 yen in the mid-morning session. Subsequently, although the market development was characterized by a stalemate, there were also moments in the afternoon session when the price briefly exceeded the high of 38,560.10 yen set in the morning.
The Nikkei average has rebounded and is fluctuating slightly while waiting for nvidia's earnings report.
On the 18th, the USA market was mixed. The Dow Jones Industrial Average closed the trading session at 43,389.60, down 55.39 points, while the NASDAQ ended at 18,791.81, up 111.69 points. With limited news at the opening, the market was mixed. The unexpected improvement in the November NAHB Housing Market Index and strong growth expectations provided support, but the Dow was pressured by profit-taking sales and traded weakly throughout the day. The NASDAQ was supported by the rise of electric car maker Tesla, a decline in long-term interest rates, and expectations for the earnings of semiconductor company NVIDIA.
Chordia---a biotech venture advancing the development of anticancer drugs that could become block inc.
Chordia Therapeutics <190A> is a biotech venture founded by drug discovery researchers who spun out from takeda pharmaceuticals sp adr <4502>, specializing in the development of low molecular weight anti-cancer drugs. The core business ranges from exploratory research to clinical research, and domestically, it conducts manufacturing and sales on its own through a partnership strategy, aiming for early monetization by licensing out overseas. It was listed on the Tokyo Stock Exchange Growth Market in June 2024.
GRAIL Announces The First Patient Has Been Tested For Eligibility With Its Non-Small Cell Lung Cancer CtDNA Assay In The TROPION-Lung12 Phase 3 Study, Sponsored By AstraZeneca In Collaboration With Daiichi Sankyo